Complaints after COVID are persistent and enormously limiting for a substantial group of people

Recently, JMIR Public Health and Surveillance published an article on how people with persistent symptoms after COVID-19, who used the allied health care scheme, recovered during the first six months after starting treatment. From IQ Health, Koen Verburg, Maud Graff, Philip van der Wees and Thomas Hoogeboom co-authored this article.

This study shows, in line with other (inter)national studies, that for a substantial group of people the symptoms after COVID are persistent and enormously limiting. In addition, it appears to be difficult to identify the group with poorer recovery at the very start of treatment.
This is the first of several publications to follow from the #ParaCov consortium. Together, these studies are going to paint a picture about the allied health care scheme as introduced in the Netherlands to support people with post-COVID symptoms.

Read the publication here: Evaluation of Primary Allied Health Care in Patients Recovering From COVID-19 at 6-Month Follow-up: Dutch Nationwide Prospective Cohort Study